| # | Drug | Count |
|---|---|---|
| 0 | RUXOLITINIB | 77 |
| 1 | VENETOCLAX | 48 |
| 2 | CYTARABINE | 44 |
| 3 | CYCLOPHOSPHAMIDE | 41 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 41 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 41 |
| 6 | METHOTREXATE SODIUM | 36 |
| 7 | AZACITIDINE | 33 |
| 8 | METHOTREXATE | 33 |
| 9 | BLINATUMOMAB | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIUM CARBONATE ANTACID | 1 | 0.0130 |
| 1 | MEDICATED HEMORRHOIDAL WIPES | 1 | 0.0115 |
| 2 | ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE | 1 | 0.0086 |
| 3 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 20 | 0.0082 |
| 4 | AXATILIMAB-CSFR | 1 | 0.0061 |
| 5 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 6 | TRABECTEDIN | 9 | 0.0038 |
| 7 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| 8 | ESMOLOL HYDROCHLORIDE | 1 | 0.0037 |
| 9 | INOTUZUMAB OZOGAMICIN | 10 | 0.0033 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 91 |
| 1 | Kinase Inhibitor [EPC] | 87 |
| 2 | Janus Kinase Inhibitor [EPC] | 77 |
| 3 | Corticosteroid [EPC] | 74 |
| 4 | Alkylating Drug [EPC] | 57 |
| 5 | BCL-2 Inhibitor [EPC] | 48 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 33 |
| 7 | Platinum-based Drug [EPC] | 29 |
| 8 | Proton Pump Inhibitor [EPC] | 29 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 20 | 0.0082 |
| 1 | CD22-directed Immunoconjugate [EPC] | 10 | 0.0033 |
| 2 | CD33-directed Immunoconjugate [EPC] | 9 | 0.0025 |
| 3 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 12 | 0.0008 |
| 5 | BCL-2 Inhibitor [EPC] | 48 | 0.0008 |
| 6 | Janus Kinase Inhibitor [EPC] | 77 | 0.0005 |
| 7 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Echinocandin Antifungal [EPC] | 3 | 0.0004 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 91 | 0.0003 |